Durable Response in Patients With Thymic Carcinoma Treated With Pembrolizumab After Prolonged Follow-Up

被引：45
|
作者：
Giaccone, Giuseppe [1 ]
Kim, Chul [1 ]
机构：
[1] Cornell Univ, Weill Cornell Med, Washington, DC USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2021年 / 16卷 / 03期
关键词：
Thymic carcinoma; Pembrolizumab; Survival; Response;
D O I：
10.1016/j.jtho.2020.11.003
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Here, we present an update of a phase 2 study of pembrolizumab in patients with advanced thymic carcinoma who failed previous therapies. Duration of response was approximately 3 years, and median survival was in excess of 2 years with a 5-year survival rate of 18%. The higher than expected incidence of severe autoimmune disorders (15%) did not substantially increase with a longer follow-up. Pembrolizumab induces durable responses in patients with thymic carcinoma. Careful selection of patients and monitoring of toxicities are warranted. (C) 2020 International Association for the Study of Lung Cancer. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码：483 / 485
页数：3
相关论文
共 50 条
  • [21] Panendoscopy during follow-up in laryngeal carcinoma patients after radiotherapy
    Stanisz, Isabella
    Janik, Stefan
    Grasl, Matthaeus Christoph
    Erovic, Boban M.
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2020, 42 (12): : 3601 - 3608
  • [22] FOLLOW-UP AFTER CYSTECTOMY FOR CARCINOMA OF THE BLADDER
    MONTIE, JE
    UROLOGIC CLINICS OF NORTH AMERICA, 1994, 21 (04) : 639 - 643
  • [23] Durable Complete Response After Discontinuation of Pembrolizumab in Patients With Metastatic Melanoma
    Robert, Caroline
    Ribas, Antoni
    Hamid, Omid
    Daud, Adil
    Wolchok, Jedd D.
    Joshua, Anthony M.
    Hwu, Wen-Jen
    Weber, Jeffrey S.
    Gangadhar, Tara C.
    Joseph, Richard W.
    Dronca, Roxana
    Patnaik, Amita
    Zarour, Hassane
    Kefford, Richard
    Hersey, Peter
    Zhang, Jin
    Anderson, James
    Diede, Scott J.
    Ebbinghaus, Scot
    Hodi, F. Stephen
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (17) : 1668 - +
  • [24] Haematic follow-up of patients treated with clozapine
    Pons, A
    Romero, A
    Carné, X
    Massana, G
    EUROPEAN PSYCHIATRY, 2005, 20 : S66 - S67
  • [25] FOLLOW-UP OF PATIENTS WITH ENDOMETRIOSIS TREATED WITH DANAZOL
    CHALMERS, JA
    SHERVINGTON, PC
    POSTGRADUATE MEDICAL JOURNAL, 1979, 55 : 44 - 47
  • [26] Prolonged follow-up of multinodular goitre patients treated with radioiodine preceded or not by human recombinant TSH
    Cardia, MS
    Rubio, IGS
    Medeiros-Neto, G
    CLINICAL ENDOCRINOLOGY, 2006, 64 (04) : 474 - 474
  • [27] Longterm follow-up of patients treated with mitoxantrone
    Daigle, A. C.
    Rizvi, S. A.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 684 - 684
  • [28] Respiratory follow-up of patients treated with nusinersen
    Ergenekon, Pinar
    Yegit, Cansu Yilmaz
    Eralp, Ela Erdem
    Gokdemir, Yasemin
    Thomas, Gulten Ozturk
    Unver, Olcay
    Evkaya, Ayca
    Saygi, Evrim Karadag
    Turkdogan, Dilsad
    Karadag, Bulent
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [29] Drastic response of sunitinib after failure of Lenvatinib in patients with previously treated thymic carcinoma
    Kaira, Kyoichi
    Imai, Hisao
    Japan, Hiroshi Kagamu
    LUNG CANCER, 2024, 189
  • [30] A FOLLOW-UP OF THE PROTEIN PATTERN AFTER OPERATIONS IN PATIENTS TREATED WITH AN ORAL ENZYME
    BRUNI, M
    TREVANO, GMQ
    BARESI, A
    BELLINZONI, G
    ARZNEIMITTELFORSCHUNG-DRUG RESEARCH, 1980, 30-2 (11): : 1922 - 1925
12345